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Alternative splicing occurs in over 90% of mammalian genes and plays a central role in generation of biological complexity, and the misregulation of splicing is involved in an expanding list of human diseases. Around 10% of human pathogenic mutations reported in Human Gene Mutation Database (HGMD) have been found to affect splicing (Soemedi et al., 2017) , and this very likely represents an underestimate. In addition to canonical splice signals such as splice sites recognized by the core spliceosomal components, the great diversity of gene splicing is dramatically affected by a plethora of cis-regulatory elements embedded in the exon or flanking intronic sequences that are recognized by numerous trans-acting splicing factors (such as RNA binding proteins or RBPs). It is the combined effects of these elements that constitute the ''splicing code'' (Wang and Burge, 2008) . Efforts to understand this code have previously entailed extensive modeling of combinations of diverse RNA features (Barash et al., 2010) or an integrated Bayesian model (Zhang et al., 2010) , but challenges remain. Experimental approaches, such as splicing reporters based on ''minigenes'' carrying specific mutations, are still the most direct and reliable assessment whether a mutation influences recognition of an exon and potentially results in phenotypic changes. However, these methods are time consuming and not applicable for either massive or novel splicing mutation detection. With the advance of next-generation sequencing technologies and machine learning, a series of in silico tools (Xiong et al., 2015) , alone or in combination with experimental tools (Adamson et al., 2018; Cheung et al., 2019; Soemedi et al., 2017) , have been designed to help predict the splicing-altering mutations on a genome-wide scale. These studies have shed important insights into the splicing code, especially in evaluating the pathogenic roles of noncoding sequence variants, which were previously of unknown clinical significance. However, the accuracy of the current state-of-the-art splicing predictors remain far from perfect, and how genomic sequence context impacts the effects of mutations is frequently unclear. In this issue of Cell, two studies (Baeza-Centurion et al., 2019; Jaganathan et al., 2019) have made exciting progress toward addressing these challenges.
To assess the splicing-altering effects of genomic variants, especially those of noncoding mutations, Jaganathan et al. (2019) have developed a deep residual neural network based on pre-mRNA transcript sequences. Compared to previous efforts in this direction, this method predicts splice sites using long-range (i.e., 5 kb on each side) primary genomic sequence flanking each position as input. Deep learning models automatically extract sequence determinates predictive of splice sites without the requirement for explicitly extracting features that are related to splicing (e.g., exonic or intronic splicing enhancers or silencers). Importantly, the authors find that long-range sequence determinates (e.g., exon and/or intron lengths) are essential for distinguishing functional splice sites from nonfunctional sites (Figure 1, top panel) . While previous computational predictions typically suffer from relative low prediction accuracy (especially in predicting non-coding mutations), this group reports that their model can achieve top-k accuracy of 95% for pre-mRNA transcripts of protein-coding genes and 84% for long intergenic noncoding RNAs (lincRNAs). The high accuracy of prediction for lincRNAs suggests that the sequence-based deep learning model likely approximates the behavior of the spliceosome in recognizing the splice sites rather than reflecting other confounding factors such as protein-coding constraints. The validity of this model is further supported by three orthogonal lines of evidence: the high validation rate in RNA-seq experiments, the depletion of synonymous and intronic mutations with predicted splice-altering consequence in the human population, and the enrichment of de novo cryptic splice mutations in patients affected by autism and intellectual disability. In particular, Jaganathan et al. (2019) estimated that synonymous and intronic variants can account for 9%-11% of pathogenic mutations in patients with rare genetic disorders, indicating that the role of non-coding mutations in human disease etiology is currently underappreciated.
When predicting the impact of a mutation on splicing, most studies focus on how such a mutation alters splicingregulatory elements. It was previously shown that the effect of splicing-regulatory elements can be highly context dependent (Goren et al., 2006) , but the underlying principles have been unclear. To approach this problem, Baeza-Centurion et al., (2019) propose a global scaling law that governs how the impact of a mutation depends on the genomic context (Figure 1, bottom panel) . The group focuses on alternative splicing of human FAS exon 6, which switches the resulting protein from a pro-to anti-apoptotic molecule. Interestingly, the orthologous exon in new world monkeys, which is a few nucleotides different from the human version, is nearly constitutively included. Baeza-Centurion et al. (2019) investigate the combined effects of mutations that led to the emergence of the human exon during evolution by testing all possible 3,072 genotypes due to variation at 11 positions on exon 6 since the last common ancestor of primates. By exploring this combinatorially complete genotype space, they observe that mutations have non-independent effects on splicing and their effects scale non-monotonically with the starting inclusion level of the exon in different genomic contexts. In particular, each mutation has its maximum effect on splicing at specific intermediate start inclusion level, which is inversely and linearly associated with the strength of the mutation. Mathematical modeling suggests that the non-monotonicity in the effects of mutations may arise from the mutually exclusive competitions between splice sites. This law also applies to other mutually exclusive molecular events, like genome-wide cis and trans perturbations of splicing (Baeza-Centurion et al., 2019). Moreover, Baeza-Centurion et al. (2019) find that incorporating the global scaling law and pairwise interactions between neighboring mutations allows highly accurate prediction of the splicing outcomes resulting from complex genotypes with up to 10 mutations.
Intriguingly, while having different focus and using a different approach, Jaganathan et al. (2019) independently proposes that exons with intermediate inclusion levels (as approximated by prediction scores) have more of a tendency to be affected by splicing mutations or be alternatively spliced than those with maximum or minimum inclusion levels -a conclusion consistent with the non-monotonic scaling law proposed by Baeza-Centurion et al. (2019) . Further, Jaganathan et al. (2019) demonstrate that weak or intermediate cryptic splice mutations, rather than the ones with high predicted scores, play central roles in generating tissue specificity. The context-dependence of spicing altering mutations may help to explain several interesting observations. For example, the perturbation of the same trans acting RBP has different effects on different target exons, which might be a result of diverse initial inclusion levels of targets. The evolution of a consti-tutive exon into an alternative exon likely requires multiple nucleotide substitutions as a compensation for the scaling law that minimizes the effects of mutations when the exon is near full inclusion.
The deep learning approach used by Jaganathan et al. (2019) is completely agnostic to prior knowledge of the splicing code. While such an approach is powerful in making qualitative or quantitative predictions, the causal biology is frequently not intuitive. The study by Baeza-Centurion et al. (2019) proves the value of knowledge-based mathematical modeling in deciphering the effects of splicing mutations and the underlying mechanisms. Although our understanding of how aberrations in the splicing code lead to human disease is likely still far from complete, the work from Jaganathan et al. (2019) and Baeza-Centurion et al. (2019) represents exciting steps. Together, these two studies suggest that the high-density information encoded in sequence context is likely essential to achieve a deeper understanding of the splicing code. Cell 176, January 24, 2019 415 By in vivo screening in zebrafish larvae, Wheeler et al. identify environmental agents that directly modulate transcriptional programs of astrocytes. The herbicide linuron exploits the unfolded protein response pathway to induce a pro-inflammatory program in reactive astrocytes that potentiates inflammatory tissue damage in the CNS.
Accumulating evidence suggests that environmental cues modulate pathogenic processes in the CNS. However, without defining distinct cellular and molecular targets in the CNS, these observations will remain in the realm of pure correlation. Mechanistically, environmental triggers might be sensed by the immune system associated with the body's surface areas. Then, immune cells, which are motile, might traffic to the CNS and elicit responses in this compartment remote from their original site of activation. More recently, microbial products have been suggested to directly impact on microglial cells, the resident immune cells of the CNS, and control their morphology and function (Erny et al., 2015; Rothhammer et al., 2018) . In this issue of Cell, Wheeler et al. (2019) now take the next step and explore the concept that extrinsic compounds are directly sensed by CNS intrinsic cells. A bold idea at first glimpse, the descent of astrocytes from ectoderm, the germ layer that forms the lining tissues of the body with the outside world, may have imprinted in them traces of the machinery to respond to environmental cues.
Based on this rationale, Wheeler et al. establish a novel screening method of chemical compounds to test their effects on gene expression in glial cells (Figure 1) . After preselecting a number of chemical compounds of the U.S. Environmental Protection Agency ToxCast database that were likely to modulate pathways known to be involved in inflammation and neurodegeneration, the authors directly add these compounds to zebrafish larvae exposed to lipopolysaccharide (LPS) and cuprizone (as a model of inflammatory demyelination in the CNS). Some of the compounds are shown to have the capacity to significantly modulate gene expression in GFP-labeled zebrafish radial glial cells and are validated to induce similar gene expression alterations in primary mouse astrocytes. The herbicide linuron is demonstrated to be a potent agent to induce NOS2 in astrocytes exposed to inflammatory stress. On the molecular level, linuron binds to the ligand-activated endoplasmic
